Latest call day: 2026-10-23 · full consensus board · graded history
Price (daily close, 2026-10-23)
Trailing returns (daily closes)
Today's calls AI
| Pharma & Managed Care · Donchian | UP 92% | Donchian — position within the Donchian channel. ELV ranks #2 of 13 in Pharma & Managed Care (92% bullish percentile), so the agent calls it UP for the next session. |
| Pharma & Managed Care · OBV Trend | UP 92% | OBV Trend — on-balance-volume accumulation. ELV ranks #2 of 13 in Pharma & Managed Care (92% bullish percentile), so the agent calls it UP for the next session. |
| Pharma & Managed Care · RSI Mean-Reversion | DOWN 92% | RSI Mean-Reversion — oversold up / overbought down. ELV ranks #6 of 13 in Pharma & Managed Care (92% bearish percentile, RSI 88), so the agent calls it DOWN for the next session. |
| Pharma & Managed Care · Momentum | UP 83% | Momentum — trailing return (trend-following). ELV ranks #3 of 13 in Pharma & Managed Care (83% bullish percentile, signal +11.8%), so the agent calls it UP for the next session. |
| Pharma & Managed Care · Regime Switch | UP 83% | Regime Switch — the market looks trending, so it ranked on Momentum. ELV ranks #3 of 13 in Pharma & Managed Care (83% bullish percentile), so the agent calls it UP for the next session. |
| Pharma & Managed Care · Breakout | UP 75% | Breakout — pushing above the prior channel high. ELV ranks #4 of 13 in Pharma & Managed Care (75% bullish percentile, signal +1.2%), so the agent calls it UP for the next session. |
| Pharma & Managed Care · MACD | UP 75% | MACD — MACD histogram momentum crossover. ELV ranks #4 of 13 in Pharma & Managed Care (75% bullish percentile), so the agent calls it UP for the next session. |
| Pharma & Managed Care · Quality | DOWN 75% | Quality — operating margin plus revenue growth. ELV ranks #8 of 13 in Pharma & Managed Care (75% bearish percentile), so the agent calls it DOWN for the next session. |
| Pharma & Managed Care · Long-Term Reversal | UP 42% | Long-Term Reversal — year-long losers rebound. ELV ranks #8 of 13 in Pharma & Managed Care (42% bullish percentile, signal -29.8%), so the agent calls it UP for the next session. |
Best agents on ELV (graded record)
| Pharma & Managed Care · Bollinger Reversion | 59% | 30/51 correct | DOWN |
| Pharma & Managed Care · LightGBM | 58% | 14/24 correct | UP |
| Pharma & Managed Care · RSI Mean-Reversion | 58% | 29/50 correct | DOWN |
| Pharma & Managed Care · Regime Switch | 57% | 26/46 correct | UP |
| Pharma & Managed Care · Mean-Reversion | 54% | 35/65 correct | UP |
| Pharma & Managed Care · Volume Thrust | 53% | 16/30 correct | UP |
| Pharma & Managed Care · Quality | 52% | 44/84 correct | DOWN |
| Pharma & Managed Care · SOTA Ensemble | 50% | 11/22 correct | DOWN |
| SOTA Ensemble Agent | 50% | 1/2 correct | DOWN |
| Pharma & Managed Care · Low Volatility | 49% | 18/37 correct | DOWN |
Recent news
| 2026-10-24 | Elevance Health raises 2026 guidance as Elevance Health stock trades at EUR 393.10 · ad-hoc-news.de |
| 2026-10-23 | ELV vs. RVTY: Which Stock Is the Better Value Option? · yf_tkr_ELV |
| 2026-10-23 | Elevance Health lifts outlook. Elevance Health stock costs EUR 395.75 at USD 94.2 billion value · AD HOC NEWS |
| 2026-10-23 | Elevance Health (ELV) Stock Rallies As Q3 Results Tighten Margin Focus · yf_tkr_ELV |
| 2026-10-22 | ELV Q3 deep dive: Carelon expansion and Medicaid margin actions underpin raised outlook · yf_tkr_ELV |
| 2026-10-22 | Elevance: 3 Key Takeaways for Long-Term Investors · yf_tkr_ELV |
How grading works: every call is locked before the open and scored on the session's open→close move — see the methodology.
Open Fortivio.AI →Model-generated predictions with a live graded record — not investment advice. 模型生成的预测，非投资建议。